ES2426679T3 - Intermedios y procesos para preparar el ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1H-indol-1-acético - Google Patents

Intermedios y procesos para preparar el ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1H-indol-1-acético Download PDF

Info

Publication number
ES2426679T3
ES2426679T3 ES10752114T ES10752114T ES2426679T3 ES 2426679 T3 ES2426679 T3 ES 2426679T3 ES 10752114 T ES10752114 T ES 10752114T ES 10752114 T ES10752114 T ES 10752114T ES 2426679 T3 ES2426679 T3 ES 2426679T3
Authority
ES
Spain
Prior art keywords
formula
compound
alkyl
hydrogen
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10752114T
Other languages
English (en)
Spanish (es)
Inventor
Debra Ainge
Michael Butters
Eric Merifield
Ravi Ramakrishnan
Ravi Naidu Rayapati
Parhalad Ray Sharma
Colin Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of ES2426679T3 publication Critical patent/ES2426679T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES10752114T 2009-07-06 2010-07-05 Intermedios y procesos para preparar el ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1H-indol-1-acético Active ES2426679T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22316309P 2009-07-06 2009-07-06
US223163P 2009-07-06
PCT/GB2010/051100 WO2011004182A1 (en) 2009-07-06 2010-07-05 Intermediates and processes for the preparation of 4- (acetylamino) ) -3- [ (4-chloro-phenyl) thio] -2-methyl-1h-indole-1-acetic acid

Publications (1)

Publication Number Publication Date
ES2426679T3 true ES2426679T3 (es) 2013-10-24

Family

ID=42780497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10752114T Active ES2426679T3 (es) 2009-07-06 2010-07-05 Intermedios y procesos para preparar el ácido 4-(acetilamino)-3-[(4-clorofenil)tio]-2-metil-1H-indol-1-acético

Country Status (16)

Country Link
US (1) US8227622B2 (enExample)
EP (1) EP2451780B1 (enExample)
JP (1) JP5675800B2 (enExample)
KR (1) KR101752932B1 (enExample)
CN (1) CN102482214B (enExample)
AR (1) AR077457A1 (enExample)
AU (1) AU2010270050B9 (enExample)
BR (1) BR112012000353B1 (enExample)
CA (1) CA2767132C (enExample)
ES (1) ES2426679T3 (enExample)
IL (1) IL217088A0 (enExample)
MX (1) MX2012000229A (enExample)
RU (1) RU2551852C2 (enExample)
SG (1) SG177286A1 (enExample)
TW (1) TW201118067A (enExample)
WO (1) WO2011004182A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104817544B (zh) * 2015-03-23 2017-05-10 三峡大学 一种四氢吲哚‑4‑酮肟类药物,制备方法及其应用
JP6472419B2 (ja) * 2015-09-30 2019-02-20 富士フイルム株式会社 芳香族化合物の製造方法
JP6452584B2 (ja) * 2015-09-30 2019-01-16 富士フイルム株式会社 芳香族化合物の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916841B2 (en) 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
WO2001032621A1 (en) 1999-10-29 2001-05-10 Wakunaga Pharmaceutical Co., Ltd. Novel indole derivatives and drugs containing the same as the active ingredient
TWI317634B (en) 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
GB0428100D0 (en) 2004-12-23 2005-01-26 Astrazeneca Ab Chemical processes & intermediates
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
JP2009538289A (ja) 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
CA2654026A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
CA2656150A1 (en) 2006-06-28 2008-01-03 Sanofi-Aventis New cxcr2 inhibitors

Also Published As

Publication number Publication date
TW201118067A (en) 2011-06-01
JP2012532186A (ja) 2012-12-13
BR112012000353A2 (pt) 2017-06-13
JP5675800B2 (ja) 2015-02-25
IL217088A0 (en) 2012-02-29
US8227622B2 (en) 2012-07-24
WO2011004182A1 (en) 2011-01-13
AU2010270050A1 (en) 2012-02-02
CA2767132C (en) 2017-06-20
SG177286A1 (en) 2012-02-28
AU2010270050B9 (en) 2013-06-27
US20110046394A1 (en) 2011-02-24
CN102482214B (zh) 2014-08-27
AU2010270050B2 (en) 2013-06-06
CN102482214A (zh) 2012-05-30
RU2012103466A (ru) 2013-08-20
EP2451780B1 (en) 2013-06-19
KR101752932B1 (ko) 2017-07-03
RU2551852C2 (ru) 2015-05-27
EP2451780A1 (en) 2012-05-16
AR077457A1 (es) 2011-08-31
MX2012000229A (es) 2012-01-25
HK1169404A1 (en) 2013-01-25
CA2767132A1 (en) 2011-01-13
BR112012000353B1 (pt) 2020-06-02
KR20120030525A (ko) 2012-03-28

Similar Documents

Publication Publication Date Title
JP5628305B2 (ja) 置換された2−フルオロアクリル酸誘導体の製造法
ES2201397T3 (es) Procedimiento para la preparacion de silidenafilo.
RU2551852C2 (ru) Промежуточные соединения и способы получения 4-(ацетиламино)-3-[(4-хлорфенил)тио]-2-метил-1н-индол-1-уксусной кислоты
CN109053505A (zh) 一种非罗考昔重要中间体的合成方法
Breuer et al. The synthesis of shihunine and related compounds from ortho-carboxyphenyl cyclopropyl ketone
JP5826167B2 (ja) オキシインドールおよびオルト置換されたアニリンを生成するための方法ならびに合成のための中間生成物としてのそれらの使用
AU735516B2 (en) Process for preparing 4-substituted-1H-indole-3-glyoxamides
ES2955674T3 (es) Método para producir derivados de espirocíclicos cis-alcoxi-sustituidos 1-h-pirrolidina-2,4-diona
ES2344291B1 (es) Metodo para producir un compuesto de dibenzoxepina.
CN100548981C (zh) 制备n-取代的邻苯二甲酰亚胺的方法
CN104529924A (zh) 5-环丙基-4-[2-甲硫基-4-(三氟甲基)苯甲酰基]异恶唑的制备方法
HK1169404B (en) Intermediates and processes for the preparation of 4- (acetylamino)) -3-[(4-chloro-phenyl) thio]-2-methyl-1h-indole-1-acetic acid
SU1660581A3 (ru) Способ получени производных хинолиндиона
Yamada et al. Simple syntheses of analogs of a wasabi phytoalexin
US4925958A (en) Process for the preparation of N-alkoxycarbonylmethyl-N-formyl-amines and -anilines
DK164550B (da) Derivat af thienyl-2-malonsyreester til brug som udgangsmateriale ved fremstilling af 2-thiopheneddikesyreforbindelser
Kogan 3-Indolylphenylacetonitriles
WO1987003278A1 (en) Synthetic routes to cyclopentanecarboxylic acid derivatives